Cargando…

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine

Type 2 diabetes mellitus (T2DM) is a chronic disease that has reached the levels of a global epidemic. In order to achieve optimal glucose control, it is often necessary to rely on combination therapy of multiple drugs or insulin because uncontrolled glucose levels result in T2DM progression and enh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannino, Gaia Chiara, Andreozzi, Francesco, Sesti, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590177/ https://www.ncbi.nlm.nih.gov/pubmed/30515958 http://dx.doi.org/10.1002/dmrr.3109

Ejemplares similares

Are Circulating Mg(2+) Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes?
por: Spiga, Rosangela, et al.
Publicado: (2019)

Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals
por: Andreozzi, Francesco, et al.
Publicado: (2017)

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients
por: Mannino, Gaia Chiara, et al.
Publicado: (2019)

Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus
por: Sciacqua, Angela, et al.
Publicado: (2021)

A polymorphism at IGF1 locus is associated with anemia
por: Marini, Maria Adelaide, et al.
Publicado: (2017)

A Fasting Insulin–Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity
por: Mannino, Gaia Chiara, et al.
Publicado: (2013)

Insulin-like growth factor-1 is a negative modulator of glucagon secretion
por: Mancuso, Elettra, et al.
Publicado: (2017)

Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeutics
por: Grossman, Iris, et al.
Publicado: (2010)

The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
por: Andreozzi, Francesco, et al.
Publicado: (2016)

Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-naïve hypertensive individuals
por: Cefalo, Chiara M. A., et al.
Publicado: (2023)

Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes
por: Ministrini, Stefano, et al.
Publicado: (2021)

Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects
por: Succurro, Elena, et al.
Publicado: (2021)

The polymorphism rs35767 at IGF1 locus is associated with serum urate levels
por: Mannino, Gaia C., et al.
Publicado: (2018)

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
por: Heo, Chan Uk, et al.
Publicado: (2019)

Association between Serum Mg(2+) Concentrations and Cardiovascular Organ Damage in a Cohort of Adult Subjects
por: Mancuso, Elettra, et al.
Publicado: (2020)

The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness
por: Averta, Carolina, et al.
Publicado: (2022)

The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals
por: Mannino, Gaia Chiara, et al.
Publicado: (2021)

A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity
por: Andreozzi, Francesco, et al.
Publicado: (2012)

Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes
por: Cassano, Velia, et al.
Publicado: (2022)

Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study
por: Fiorentino, Teresa Vanessa, et al.
Publicado: (2018)

Analysis of age-dependent gene-expression in human tissues for studying diabetes comorbidities
por: Guzzi, Pietro Hiram, et al.
Publicado: (2023)

Pharmacogenetics and personalized treatment of type 2 diabetes
por: Semiz, Sabina, et al.
Publicado: (2013)

Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
por: Nasykhova, Yulia A., et al.
Publicado: (2020)

Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence?
por: Mannino, Gaia Chiara, et al.
Publicado: (2022)

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
por: Fioretto, Paola, et al.
Publicado: (2015)

The Pharmacogenetics of Type 2 Diabetes: A Systematic Review
por: Maruthur, Nisa M., et al.
Publicado: (2014)

Pharmacogenetics: The future medicine
por: Saini, Rajiv, et al.
Publicado: (2010)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
por: Lee, Su-Jun
Publicado: (2013)

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction
por: Fiorentino, Teresa Vanessa, et al.
Publicado: (2017)

Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
por: Huang, Chunmei, et al.
Publicado: (2011)

The Triglycerides and Glucose (TyG) Index Is Associated with 1-Hour Glucose Levels during an OGTT
por: Massimino, Mattia, et al.
Publicado: (2022)

Multi-disciplinary Consensus Statement Document Vaccinal prevention in adult patients with diabetes mellitus
por: Icardi, G., et al.
Publicado: (2018)

Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
por: Pollastro, Carla, et al.
Publicado: (2015)

Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model
por: Cassano, Velia, et al.
Publicado: (2020)

Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open‐label, crossover, active‐comparator FIORE trial
por: Succurro, Elena, et al.
Publicado: (2022)

Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
por: Rofaiel, Sarah, et al.
Publicado: (2010)

Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine
por: Simeon, Vittorio, et al.
Publicado: (2015)

Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals
por: Marini, Maria Adelaide, et al.
Publicado: (2017)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2aqpdideji1d8p110bbe68cbf8